Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 May;7(2):134-147.
doi: 10.1159/000484619. Epub 2017 Dec 13.

Management of Hepatocellular Carcinoma in Japan as a World-Leading Model

Affiliations
Editorial

Management of Hepatocellular Carcinoma in Japan as a World-Leading Model

Masatoshi Kudo. Liver Cancer. 2018 May.
No abstract available

PubMed Disclaimer

Figures

None
Prof. M. Kudo Editor Liver Cancer
Fig. 1
Fig. 1
Treatment modality for initially diagnosed HCC.
Fig. 2
Fig. 2
BCLC stage at the initial detection of HCC: comparison between Western countries and Japan.
Fig. 3
Fig. 3
Improvement of 5-year survival rate in patients with HCC. Results of the nationwide survey of the Liver Cancer Study Group of Japan (n = 173,378). MDCT, multidetector-row CT; PEIT, percutaneous ethanol injection therapy; IFN Tx, interferon treatment; DCP, des-γ-carboxy protein.
Fig. 4
Fig. 4
Improvement of overall survival in patients with HCC. Results of the nationwide survey of the Liver Cancer Study Group of Japan (n = 173,378). M, months. For further abbreviations, see Figure 3.
Fig. 5
Fig. 5
Improvement of treatment outcome in HCC patients with AFP value ≥400 ng/mL.
Fig. 6
Fig. 6
The Japan Society of Hepatology consensus-based HCC treatment algorithm.
Fig. 7
Fig. 7
Trend in HCC mortality in Japan.

References

    1. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397–401. - PubMed
    1. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med. 1991;32:1177–1182. - PubMed
    1. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology. 1993;17:814–819. - PubMed
    1. Honjo I, Araki C. Total resection of the right lobe of the liver; report of a successful case. J Int Coll Surg. 1955;23:23–28. - PubMed
    1. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985;161:346–350. - PubMed

Publication types

LinkOut - more resources